Navigation Links
AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy

Efficacy and Safety of Gene Therapy in Lipoprotein Lipase Deficiency Established

Amsterdam, The Netherlands - May 31, 2007 - Amsterdam Molecular Therapeutics (AMT), a leader in the field of human gene therapy, reported positive Phase I/II clinical trial results with its lead product AMT-010 (now referred to as AMT-011) in Complete Lipoprotein Lipase (LPL) deficient patients at the 10th Annual Meeting of the American Society of Gene Therapy (ASGT) in Seattle. The study's lead investigator is Erik S.G. Stroes, MD, PhD, from the University of Amsterdam Medical Center in The Netherlands.

Ronald Lorijn, CEO of AMT, said, "We believe these excellent results may represent an important milestone for the entire field of gene therapy and for the many patients who today cannot be treated. Our clinical success and the breakthrough in our production platform place us squarely at the forefront of the gene therapy field that is finally coming into its own."

AMT's products rely on a unique gene therapy platform that to date appears to circumvent many if not all of the obstacles that have prevented gene therapy to become a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and scalable AAV production platform. As such, AMT's proprietary platform holds tremendous promise for thousands of rare (orphan) diseases that are caused by one faulty gene. AMT currently has a product pipeline with six products at different stages of development.

Study design

The primary goal of the study presented at the ASGT was to investigate if AMT-010 reduces the elevated triglyceride (fat) levels and the associated risk of pancreatitis in Complete LPL deficient patients. The study design was an eight-patient open label dose-escalating study (low and mid dos
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
3. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
4. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
5. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
6. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
7. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
8. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
9. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
10. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
11. BioCryst Presents Phase I Peramivir Data at the Options for the Control of Influenza Conference

Post Your Comments:
(Date:11/6/2009)... NuVasive, Inc. (Nasdaq: ...oping products for minimally disruptive surgical t...ntment of Michael J. Lambert as Executive Vice Pre...mber 9, 2009. The Company also announced several ...chael will be an excellent complement to the NuVas...
(Date:11/6/2009)..., Nov. 6 With his proposed health ...is sights on cutting name-brand prescription drug ... into the "Part D" coverage gap, universally known...e potential cost-cutting and feel it,s a promising... powerful lobbyists want a revised program that co...
(Date:11/6/2009)...RNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: ...rt financial results for the second quarter ended ...0, 2010 on Wednesday, November 18, 2009 at 5:00 PM...to discuss those results on Thursday, November 19,...ond Quarter Results Conference Call Instructions ...
Breaking Medicine Technology:NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 3Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Implanet Using IBM Software to Protect Patients in the Event of Medical Device Recalls 56057 1Implanet Using IBM Software to Protect Patients in the Event of Medical Device Recalls 56057 2Implanet Using IBM Software to Protect Patients in the Event of Medical Device Recalls 56057 3Stater Bros Helps Customers Fight the Flu 56055 1Stater Bros Helps Customers Fight the Flu 56055 2Lead Levels in Many Lipsticks Higher Than Reported 56053 1Lead Levels in Many Lipsticks Higher Than Reported 56053 2Lead Levels in Many Lipsticks Higher Than Reported 56053 3
...widely used as the gold standard for prostate canc...s in recent diagnostic science, a recent study at ...s by other researchers have now put the utility of...PSA era is over in the United States, said Thomas ...f the study published in the October 2004 issue of...
... analog and digital television sets, so, too, do p...ween analog and digital mammography units, with th... around the country., ,As of late 2003, the U....four digital mammography units for clinical usethe...ystems, approved in January 2000 and manufactured ...
Other Medicine Technology:PSA TestingHow Much is Too Much? 2PSA TestingHow Much is Too Much? 3Digital vs. Analog Mammography 2Digital vs. Analog Mammography 3Digital vs. Analog Mammography 4
(Date:11/8/2009)...sition promotes self-assurance, research finds , ... mother may have been right when she told you to s...sture could make you feel more confident about you...ting up straight gives a good impression to other ... a psychology professor at Ohio State University, ...
(Date:11/8/2009)...hing Taxes Nail Nation,s Job Creators ,, WASHIN...e to U.S. House passage of the health care bill (H...ouncil (SBE Council) president & CEO Karen Ker... no mistake, those voting for H.R. 3962 voted to b...and crushing taxes and penalties. Even in the best...
(Date:11/8/2009)...ew book called "Preventing and Healing AIDS T...aldo shows that AIDS is a result of multiple, repe...d immune system stressor agents, which can be eith..., emotional. , Oakland, ... 8, 2009, cell biologists, physicians, chemists an...
(Date:11/8/2009)...en’s Health Network (MHN) urges military vet...y those linked to exposure to chemicals, atomic ag...der cancer is one of those cancers that is two tim...o once smoked or currently smoke cigarettes. , ...er 8, 2009 -- Men’s Health Network (MHN) kic...
(Date:11/8/2009)...t mean the battle is won," said Dr. Charmaine Yoes...e/ -- In a vote of 240-194, the Stupak-Ellsworth-P... prohibit abortion mandates and funding in HR 3962... for Life Action President and CEO Dr. Charmaine Y...tory for the pro-life Americans across this countr...
Breaking Medicine News(10 mins):Health News:Good Posture May Inspire Confidence 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2
... the mammalian eye also detects light for a number...is the timing of the sleep/wake cycle, which is sy...n pacemaker in the hypothalamus. , In a study pu...tact, suggesting that visual and non-visual respon...
...ease,Control and Prevention (CDC), with timely ass...Infection Control and Epidemiology (APIC), is,deve... of,healthcare-associated infection (HAI) data fro...vide data already,collected using a commercial sys...
...are insurer,MedAmerica, will expand with a new car...surance Company of Florida (Home Office: Winter Pa...rtunities of the Florida market,MedAmerica decided...Simplicity ii(SM), which is the highest,independen...
...have a marked cut-off for fertility, researchers s...sts have found no evidence that female chimpanzees...s do -- even though their ability to reproduce ten...ans in their forties," researcher Melissa Emery Th...
...tingham and Leicester are collaborating in the use...antify the air spaces inside the lungs and the re... childhood disease and later degenerative lung dis...iversity of Nottingham. Researchers at the Univers...
...e University of Missouri and Imperial College Lond...ected against the virus that causes AIDS and many ...hed in the Dec. 14 edition of The Journal of Biolo...hool of Medicine, and Anne Dell, an investigator a...
Other Medicine News:Health News:Blind humans lacking rods and cones retain normal responses to non-visual effects of light 2Health News:Blind humans lacking rods and cones retain normal responses to non-visual effects of light 3Health News:CDC Uses New Technical Approach to Enable Hospital Reporting of Healthcare-Associated Infections 2Health News:New Long-Term Care Insurer Offers Simplified Insurance Plans in Florida 2Health News:Menopause May Be Unique to Humans 2Health News:New technique reveals insights into lung disease 2Health News:New study suggests why vaccines directed against cancer, HIV don't work 2
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
Medicine Products: